Clinical Trial Update: A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep) [NA]

View source ↗

Summary

A multicenter randomized trial is evaluating capecitabine versus endocrine therapy as maintenance after first-line capecitabine-based chemotherapy in hormone re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Endocrine therapy

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Breast Cancer | NA | Status: UNKNOWN